Infliximab-induced acne: A new case and review of published reports

Journal of Dermatological Treatment

Volumn 20, Issue 1, 2009, Pages 59-60

  Steels, Emmanuelle ^a,b   Peretz, Anne ^c   Vereecken, Pierre ^a,b,c,d  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

^d Department of Medical Oncology ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANALGESIC AGENT; CORTICOSTEROID; DOXYCYCLINE; HLA B27 ANTIGEN; INFLIXIMAB; LYMECYCLINE; MINOCYCLINE; SALAZOSULFAPYRIDINE; TETRACYCLINE;

ACNE; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BACK; CASE REPORT; CROHN DISEASE; DRUG TOLERABILITY; FACE; FEMALE; FOLLOW UP; HAND PALM; HUMAN; MALE; PARADOXICAL DRUG REACTION; PRIORITY JOURNAL; PSORIASIS; SKIN EXAMINATION;

ACNEIFORM ERUPTIONS; ADRENAL CORTEX HORMONES; ANTIBODIES, MONOCLONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MALE; MINOCYCLINE; PSORIASIS; RISK ASSESSMENT; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 61649093803     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630802155073     Document Type: Article

References (5)

1. Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: First 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9:1-14.
2. Harrison MJ, Dixon WG, Watson KD, King Y, Groves R, Hyrich KL, et al. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-TNF (alpha) therapy. Results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2008;Apr 2 [Epub ahead of print].
3. Bassi E, Poli F, Charachon A, Claudepierre P, Revuz J. Infliximab-induced acne: Report of two cases. Br J Dermatol. 2007;156:402-3.
4. Sladden MJ, Clarke PJ, Mitchell B. Infliximab-induced acne: Report of a third case. Br J Dermatol. 2008;158:172.
5. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanism of action: A comprehensive review. Pharmacol Ther. 2008;117:244-79.